We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mindray Provides Live Scan Demonstration of Its Latest Ultrasound Systems

By HospiMedica International staff writers
Posted on 14 Jul 2022

Mindray (Shenzhen, China) showcased its imaging solutions and most recent innovations designed to tackle the growing pressure in radiology at the on-site European Congress of Radiology (ECR) in Vienna. More...

The company also offered live scanning demonstrations and free courses such as satellite symposium on prostate biopsy and fusion ultrasound at the event.

At ECR 2022, Mindray provided live scanning demonstrations of its latest ultrasound systems, the Resona I9, Resona 7 and MX 7. The Resona I9 general imaging ultrasound system with innovative features from the inside out features an intelligent and clinical exam-specific control panel layout with special E-ink keys. It enables bedside exams without power cables with up to four hours of continuous scanning and provides users with extreme clarity, outstanding intelligence and enhanced diagnostic confidence. The Resona 7 is a premium ultrasound system powered by ZONE Sonography Technology and features new ZST+ platform that brings ultrasound image quality to a higher level by zone acquisition and channel data processing. The MX 7 is the most innovative, advanced and high quality miniaturized ultrasound system ever designed by Mindray. Powered by the ZST+ platform, MX7 delivers high quality ultrasound image 10 times faster than traditional Beamformer.

Mindray also demonstrated its newly-launched TEX20 diagnostic ultrasound series which fundamentally changes the conventional perspective of POC ultrasound from its predecessors, with its patient-centered information solution, extreme image clarity, clinical-oriented workflow, smart tools and thoughtful design. Also on display at the event was the Consona N Series ultrasound systems designed for primary care users featuring new and concrete solutions, that help carry out smooth diagnoses for different types of patients. The Consona N Series is ideal for routine applications in hospitals, clinics, or general imaging applications, women's health care or cardiovascular specialties.

Related Links:
Mindray 


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Immobilization System
Cranial 4Pi Immobilization
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.